A.R.T. Advisors’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
FAM
CCM
WRF
CS
CC
BG
A.R.T. Advisors's CDNA Position: Q1 2020 in Review
A.R.T. Advisors sold out of CareDx (CDNA) in Q1 2020, closing a stake of 18,804 shares — an estimated $406K sold.
A.R.T. Advisors first reported a position in CDNA in Q1 2018 and held it in 6 quarters. The position peaked at $1.21M in Q3 2019. 144 funds tracked by Wall St. Rank hold CDNA as of Q1 2020.
- A.R.T. Advisors reported no remaining CareDx position as of Q1 2020 after selling out during the quarter.
- A.R.T. Advisors sold 18,804 CareDx shares in Q1 2020, an estimated $406K.
- A.R.T. Advisors first reported a position in CareDx in Q1 2018 and held it in 6 quarters.
- A.R.T. Advisors's CareDx position peaked at $1.21M in Q3 2019.
- 144 funds tracked by Wall St. Rank held CareDx as of Q1 2020.
Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.